View Older Stories View More Recent Stories
-
iRhythm Technologies (IRTC) PT Lowered to $185 at Oppenheimer
-
iRhythm Technologies (IRTC) PT Raised to $255 at Needham
-
iRhythm Technologies (IRTC) PT Lowered to $180 at Wolfe Research
-
iRhythm Technologies (IRTC) Tops Q1 EPS by 23c, raises guidance
-
iRhythm studies show extended monitoring detects more arrhythmias
-
Q1 MedTech quarterly preview: BTIG
-
iRhythm presents cardiac monitoring data and launches education platform
-
iRhythm Technologies (IRTC) PT Lowered to $214 at Citi
-
iRhythm Technologies (IRTC) on Watch, OWS Removes Strong Sell
-
iRhythm Technologies (IRTC) PT Lowered to $200 at Truist Securities
-
iRhythm Technologies (IRTC) PT Lowered to $200 at Truist Securities
-
iRhythm Technologies (IRTC) PT Lowered to $198 at Canaccord Genuity
-
iRhythm Technologies (IRTC) Tops Q4 EPS by 16c, provides guidance
-
Off Wall Street New Strong Sell on iRhythm Technologies (IRTC)
-
Morgan Stanley on iRhythm Technologies (IRTC): 'Solid pre-announce'
-
iRhythm expects 2025 revenue to exceed $740 million guidance
-
iRhythm study shows Zio monitors perform similarly in Asian patients
-
iRhythm Technologies (IRTC) PT Raised to $220 at Freedom Capital Markets
-
iRhythm Technologies (IRTC) PT Raised to $244 at Needham
-
iRhythm Technologies (IRTC) PT Raised to $215 at BTIG
-
iRhythm Technologies (IRTC) PT Raised to $212 at Canaccord Genuity
-
iRhythm Technologies (IRTC) Tops Q3 EPS by 38c, provides guidance
-
Freedom Capital Markets Starts iRhythm Technologies (IRTC) at Buy
-
iRhythm Technologies (IRTC) PT Raised to $193 at Canaccord Genuity
-
Evercore ISI Starts iRhythm Technologies (IRTC) at In Line
-
BofA Securities Starts iRhythm Technologies (IRTC) at Buy
-
iRhythm Technologies (IRTC) Mentioned as Short at Spruce Point
-
iRhythm Technologies (IRTC) PT Raised to $175 at Oppenheimer
-
iRhythm Technologies (IRTC) PT Raised to $180 at Needham
-
iRhythm Technologies (IRTC) Tops Q2 EPS by 19c
-
iRhythm Technologies (IRTC) Tops Q2 EPS by 19c, provides guidance
-
iRhythm Technologies (IRTC) announces Board changes
-
Wells Fargo Upgrades iRhythm Technologies (IRTC) to Overweight
-
iRhythm Technologies (IRTC) PT Lowered to $139 at Canaccord Genuity
-
iRhythm Technologies (IRTC) PT Raised to $140 at BTIG
-
iRhythm Technologies (IRTC) Tops Q1 EPS by 1c
-
iRhythm Technologies (IRTC) Tops Q1 EPS by 1c, provides guidance
-
iRhythm Technologies (IRTC) Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
-
iRhythm Technologies (IRTC) PT Raised to $145 at Truist Following EBITDA/EPS Beat
-
iRhythm Technologies (IRTC) PT Raised to $145 at Truist Securities
-
iRhythm Technologies (IRTC) PT Raised to $138 at Needham
-
iRhythm Technologies (IRTC) PT Raised to $145 at JPMorgan
-
iRhythm Technologies (IRTC) PT Raised to $135 at BTIG
-
iRhythm Technologies (IRTC) PT Raised to $130 at Citi
-
iRhythm Technologies (IRTC) Tops Q4 EPS by 31c; offers guidance
-
iRhythm Technologies (IRTC) Announces Departure of Mojdeh Poul from Board
-
Oppenheimer Reiterates Outperform Rating on iRhythm Technologies (IRTC)
-
iRhythm Technologies (IRTC) PT Raised to $112 at Needham
-
iRhythm Technologies (IRTC) Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
-
iRhythm Technologies (IRTC) PT Raised to $120 at Oppenheimer

